- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07594704
Effects of Different Tunnel Methods in PICC Catheterization
May 18, 2026 updated by: Zeyin Hu, Sun Yat-sen University
Effects of Different Tunnel Methods in PICC Catheterization: A Randomized Controlled Trial
This prospective randomized controlled trial compares the effectiveness and safety of one-needle and two-needle tunneling techniques for peripherally inserted central catheter (PICC) placement, aiming to identify the optimal tunneling method to reduce catheter-related complications.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
284
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Zeyin Hu
- Phone Number: 15899954190
- Email: huzy@sysucc.org.cn
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Recruiting
- Sun yat-sen University Cancer Center
-
Contact:
- Zeyin Hu
- Phone Number: 15899954190
- Email: huzy@sysucc.org.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Aged between 18 and 75 years old;
- Educational level of primary school or above, with basic listening, speaking, reading and writing abilities, and capable of completing the questionnaire independently;
- Receiving tunneled PICC catheterization for the first time, with 4Fr single-lumen solo PICC catheter indwelling;
- Able to attend regular PICC maintenance at our hospital as scheduled after catheterization;
- Voluntarily participate in this study and sign the informed consent form for this study as well as the informed consent form for PICC catheterization.
Exclusion Criteria:
- Patients with coagulation dysfunction (INR > 1.5 / PLT < 50×10⁹/L);
- Pregnant or lactating women;
- Patients with BMI < 18.5 kg/m²;
- Patients receiving PICC catheterization via lower extremity veins;
- Patients with known or suspected allergy to components of PICC catheters.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: cancer patients who undergo PICC placement using two-needle tunnel technique
Two-needle tunnel PICC procedure:
|
Two-needle tunnel PICC procedure:
|
|
Experimental: cancer patients who undergo PICC placement using one-needle tunnel technique
Ultrasound guidance is used for vascular puncture and assisted subcutaneous tunnel creation:
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
overall PICC-related complications after catheter placement
Time Frame: 4 weeks after PICC placement
|
these complications include catheter exit site oozing, contact dermatitis, venous thrombosis, infection, catheter displacement or dislodgement, mechanical phlebitis, catheter occlusion, and catheter fracture or damage.
|
4 weeks after PICC placement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
first-puncture success rate of PICC catheterization
Time Frame: day 1 during PICC catheterization
|
day 1 during PICC catheterization
|
|
|
Bleeding during PICC placement
Time Frame: Day 1 during PICC placement
|
Day 1 during PICC placement
|
|
|
unplanned catheter removal rate of PICC
Time Frame: 4 weeks after PICC placement
|
4 weeks after PICC placement
|
|
|
pain score
Time Frame: Day 1 during PICC placement
|
Evaluated by Numerical Rating Scale , a self-report tool where individuals rate their pain intensity from 0 (no pain) to 10 (worst possible pain),with higher scores indicating more severe pain.
|
Day 1 during PICC placement
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 30, 2026
Study Registration Dates
First Submitted
May 13, 2026
First Submitted That Met QC Criteria
May 13, 2026
First Posted (Actual)
May 19, 2026
Study Record Updates
Last Update Posted (Actual)
May 22, 2026
Last Update Submitted That Met QC Criteria
May 18, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B2026-068-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PICC Line Placement
-
Medical University of WarsawActive, not recruitingVascular Access | PICC Line PlacementPoland
-
University Medical Centre LjubljanaInstitute of Oncology LjubljanaNot yet recruitingVessels; Anomaly | PICC Line Placement
-
University Hospital, BrestCompleted
-
Equipo de Terapia IntravenosaHospital San Carlos, MadridCompleted
-
Jena University HospitalCompleted
-
C. R. BardKJT Group, Inc.CompletedIndication for PICC PlacementUnited States
-
VasoNova, Inc.CompletedAny Condition Requiring a PICC PlacementUnited States
-
C. R. BardTerminatedPrimary Focus: Adult Subjects Who Require PICC PlacementUnited States
-
C. R. BardTerminatedNo Specific Conditions Under Study. Primary Focus: Adult Subjects Who Require PICC PlacementUnited States
-
Centre Hospitalier Saint Joseph Saint Luc de LyonRecruitingIV Line Placement With UltrasoundFrance
Clinical Trials on two-needle tunnel technique
-
Peking University Third HospitalThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical... and other collaboratorsNot yet recruitingAnterior Cruciate Ligament Rupture
-
Postgraduate Institute of Dental Sciences RohtakNot yet recruitingGingival RecessionIndia
-
Necmettin Erbakan UniversityCompleted
-
Universitat Internacional de CatalunyaRecruitingGingival Recession Localized ModerateSpain
-
Medical University of WarsawUnknown
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Seoul National University HospitalCompleted
-
RenJi HospitalRecruitingPatent Oval ForamenChina
-
Seoul National University HospitalUnknownBrain Neoplasm | Intracranial Aneurysm | Cerebrovascular Moyamoya DiseaseKorea, Republic of
-
Universitat Internacional de CatalunyaNot yet recruiting